{
  "ticker": "BBIO",
  "year": 2024,
  "quarter": 3,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 6,
  "transactions": [
    {
      "id": 117785,
      "issuer_name": "BridgeBio Pharma, Inc.",
      "reporting_owner": "KKR Genetic Disorder L.P.",
      "reporting_owner_cik": "0001780408",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-13",
      "transaction_shares": "5800000",
      "transaction_price": "25.75",
      "transaction_type": "S",
      "shares_after_transaction": "25260971"
    },
    {
      "id": 144438,
      "issuer_name": "BridgeBio Pharma, Inc.",
      "reporting_owner": "KKR Genetic Disorder L.P.",
      "reporting_owner_cik": "0001780408",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-13",
      "transaction_shares": "5800000",
      "transaction_price": "25.75",
      "transaction_type": "S",
      "shares_after_transaction": "25260971"
    },
    {
      "id": 173179,
      "issuer_name": "BridgeBio Pharma, Inc.",
      "reporting_owner": "KKR Genetic Disorder L.P.",
      "reporting_owner_cik": "0001780408",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-13",
      "transaction_shares": "5800000",
      "transaction_price": "25.75",
      "transaction_type": "S",
      "shares_after_transaction": "25260971"
    },
    {
      "id": 204451,
      "issuer_name": "BridgeBio Pharma, Inc.",
      "reporting_owner": "KKR Genetic Disorder L.P.",
      "reporting_owner_cik": "0001780408",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-13",
      "transaction_shares": "5800000",
      "transaction_price": "25.75",
      "transaction_type": "S",
      "shares_after_transaction": "25260971"
    },
    {
      "id": 238064,
      "issuer_name": "BridgeBio Pharma, Inc.",
      "reporting_owner": "KKR Genetic Disorder L.P.",
      "reporting_owner_cik": "0001780408",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-13",
      "transaction_shares": "5800000",
      "transaction_price": "25.75",
      "transaction_type": "S",
      "shares_after_transaction": "25260971"
    },
    {
      "id": 274930,
      "issuer_name": "BridgeBio Pharma, Inc.",
      "reporting_owner": "KKR Genetic Disorder L.P.",
      "reporting_owner_cik": "0001780408",
      "reporting_owner_position": null,
      "transaction_date": "2024-09-13",
      "transaction_shares": "5800000",
      "transaction_price": "25.75",
      "transaction_type": "S",
      "shares_after_transaction": "25260971"
    }
  ]
}